Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 442

1.
2.

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.

3.

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

Thompson HS, Valdimarsdottir HB, Duteau-Buck C, Guevarra J, Bovbjerg DH, Richmond-Avellaneda C, Amarel D, Godfrey D, Brown K, Offit K.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1579-85.

4.

Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.

Lerman C, Hughes C, Benkendorf JL, Biesecker B, Kerner J, Willison J, Eads N, Hadley D, Lynch J.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):361-7.

5.

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.

Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):369-75.

6.
7.

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.

Cappelli M, Surh L, Humphreys L, Verma S, Logan D, Hunter A, Allanson J.

Clin Genet. 1999 Jun;55(6):419-30.

PMID:
10450858
8.

Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.

Bottorff JL, Ratner PA, Balneaves LG, Richardson CG, McCullum M, Hack T, Chalmers K, Buxton J.

Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):89-95.

10.

Interest in BRCA1/2 testing in a primary care population.

Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS.

Prev Med. 2002 Jun;34(6):590-5.

PMID:
12052018
11.
12.

Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines.

Hall J, Gray S, A'Hern R, Shanley S, Watson M, Kash K, Croyle R, Eeles R.

Fam Cancer. 2009;8(1):5-13. doi: 10.1007/s10689-008-9201-0.

PMID:
18679829
13.

Factors associated with decisions about clinical BRCA1/2 testing.

Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4.

14.

Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.

Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.

Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.

PMID:
21875844
15.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology..

J Clin Oncol. 2003 Jun 15;21(12):2397-406.

PMID:
12692171
16.

Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.

Glanz K, Grove J, Lerman C, Gotay C, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):329-36.

17.

Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.

Tambor ES, Rimer BK, Strigo TS.

Am J Med Genet. 1997 Jan 10;68(1):43-9.

PMID:
8986274
19.

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.

Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF.

Am J Med Genet A. 2003 Jun 15;119A(3):266-72.

PMID:
12784290
20.

Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.

Schwartz MD, Benkendorf J, Lerman C, Isaacs C, Ryan-Robertson A, Johnson L.

Cancer. 2001 Aug 15;92(4):932-40.

PMID:
11550168
Items per page

Supplemental Content

Support Center